Cardiovascular disease (CVD) remains a national priority and primary care has a pivotal role in successfully addressing this urgent issue. This was the key message of Issues & Answers in Cardiovascular Disease 2015 conference, which participants and faculty said was the 'most successful' in the series to date.
The leading UK cardiovascular conference for the whole primary care team. Expert presenters and a down-to-earth approach help health professionals translate the latest evidence into daily practice and optimise patient care. Participants also receive 9 hours CPD credits. Book now to attend this inspirational event. Don't miss out, last few places available
New data show that after 3 years’ treatment with liraglutide, adults with obesity or who are overweight with comorbidities lost more weight, reduced blood pressure, triglycerides and cholesterol level compared with placebo.
Low socioeconomic status is linked to significant reductions in life expectancy and should be considered a major risk factor for ill health and early death in national and global health policies, according to a new study of 1.7 million people.
‘Issues & Answers in Cardiovascular Disease’ is the leading UK cardiovascular conferences for the whole primary care team. Expert presenters and a down-to-earth approach help health professionals translate the latest evidence into daily practice and optimise patient care. Participants also receive 6 hours CPD credits. Read the highlights from the 2016 conference and access presentation slides here.
Stories in this Evidence in Practice include:
- Health survey for England, 2016: The good and the bad news
- Healthy lifestyle changes have a long-term benefit for type 2 diabetes prevention
- Weight loss diets reduce the risk of premature death for people with obesity
- Very low calorie diet can achieve a remission of Type 2 Diabetes
- Dash diet plus sodium reduction lowers systolic blood pressure
- Long-term follow-up underscores benefits of lowering LDL-C in CVD primary prevention
- Blood pressure self-monitoring is more effective with professional support
- AF and other chronic conditions = higher risk of death
- Clinical trials underestimate the real-world impact of Atherosclerotic CVD
- The burden of heart failure continues to rise in the UK